Re: A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer

J Natl Cancer Inst. 2001 Mar 7;93(5):399-401. doi: 10.1093/jnci/93.5.399.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bayes Theorem
  • Carcinoma, Small Cell / drug therapy*
  • Carcinoma, Small Cell / pathology
  • Clinical Trials, Phase II as Topic
  • Clinical Trials, Phase III as Topic
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Models, Statistical*
  • Neoplasm Staging
  • Survival Analysis
  • Treatment Outcome